Johan Vansteenkiste

6PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 02, 2022
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray

|Nov 17, 2019
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer.

Benjamin Dizier, Andrea Callegaro, Muriel Debois

|Aug 02, 2019
Capmatinib for the treatment of non-small cell lung cancer.

Johan Filip Vansteenkiste, Charlotte Van De Kerkhove, Els Wauters

|Jul 11, 2018
Phenotype molding of stromal cells in the lung tumor microenvironment.

Diether Lambrechts, Els Wauters, Bram Boeckx

Pageof 1